Core Viewpoint - A class action lawsuit has been filed against Marex Group plc for alleged securities fraud, with claims of significant accounting irregularities and misleading disclosures impacting investors [1][5]. Group 1: Allegations and Findings - A report by NINGI Research on August 5, 2025, accused Marex of engaging in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to conceal losses and inflate profits [3]. - The report highlighted discrepancies, including a $17 million receivable created without basis, a subsidiary's profit inflated by 150%, and an asset sold for $2.5 million that was previously valued at $14.9 million [3]. - It was alleged that Marex concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund, misclassifying structured note issuance as income to inflate cash flow [3]. Group 2: Market Reaction - Following the publication of the report, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31 per share on August 5, 2025, with unusually high trading volume [4]. Group 3: Lawsuit Details - The class action complaint claims that Marex's management made materially false statements and failed to disclose adverse facts about the company's financial health, including inconsistencies in financial statements and reliance on misleading positive statements [5]. - Specific allegations include the sale of over-the-counter financial instruments to itself and the unreliability of Marex's financial statements due to discrepancies in intercompany transactions [5].

NEW YORK--(BUSINESS WIRE)---- $MRX #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc ("Marex†or the "Company†) (NASDAQ: MRX) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm ha ...

ATLANTA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC announces that it has filed a shareholder class action lawsuit against Marex, Inc. (“Marex” or the “Company”) (NASDAQ: MRX). The lawsuit alleges that Defendants failed to disclose to investors that: (1) the Company sold over-the-counter financial instruments to itself; (2) Marex had inconsistencies in its financial statements between its subsidiaries and related parties, including as to intercompany receivables and loans; (3) as a result of the ...

Core Viewpoint - A class action lawsuit has been filed against Marex Group PLC, alleging significant accounting irregularities and misleading disclosures that have impacted investors during the specified Class Period from May 16, 2024, to August 5, 2025 [1][5]. Summary by Sections Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1]. - Investors have a 60-day window from the notice date to move the Court to serve as lead plaintiff in this action [2][6]. Allegations Against Marex - A report by NINGI Research on August 5, 2025, accused Marex of engaging in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to conceal losses and inflate profits [3]. - Specific allegations include a $17 million receivable created without basis, a subsidiary's profit inflated by 150%, and a $14.9 million asset sold for only $2.5 million shortly after, with no loss reported [3]. - The report also claimed Marex concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund, misclassifying structured note issuance as income [3]. Market Reaction - Following the allegations, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31 per share on August 5, 2025, with unusually high trading volume [4]. Misleading Statements - The complaint alleges that Marex made materially false and misleading statements throughout the Class Period, failing to disclose critical adverse facts about its business and financial health [5]. - Specific failures included undisclosed over-the-counter financial instruments sold to itself and inconsistencies in financial statements among subsidiaries [5].

, /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all persons and entities that sold short Marex Group PLC (NASDAQ: MRX) securities between August 14, 2024 and August 5, 2025. Marex is a U.K.-based diversified global financial services platform. To be notified if a class action against Marex Group PLC Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not gu ...

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Southern District of New York against Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX), and certain of its directors and officers (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 ( ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Marex (MRX) To Contact Him Directly To Discuss Their Options If you purchased or stock in Marex and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized stockholder ...

Core Insights - Marex Group (NASDAQ: MRX) experienced a significant stock market performance, with shares rising nearly 12% following the release of preliminary third-quarter figures, outperforming the S&P 500's 0.6% increase [1] Financial Performance - For the third quarter ending September 30, Marex estimated revenue between $475 million and $485 million, indicating substantial growth from $391 million in the same quarter of 2024 [2] - The company anticipates GAAP net profit to be between $70 million and $73 million, compared to $58 million in the third quarter of 2024. Non-GAAP adjusted profit per share is projected at $0.92 to $0.97, up from $0.76 a year ago [3] Management Commentary - CEO Ian Lowitt stated that the recent performance reflects the strength and resilience of the company's franchise, designed to grow across various market environments [4] Upcoming Events - Official audited results are set to be published on November 6, accompanied by a management conference call, which will provide further insights into the quarter's performance [4]

Marex Group plc, the London-born brokerage now listed on Nasdaq under the ticker MRX, has posted another quarter of sharp growth despite a lull in global derivatives trading.The company said in a preliminary update that third-quarter revenue will come in between $475 million and $485 million, up 23% year on year at the midpoint, with adjusted profit before tax climbing 22% to as much as $101 million. Its adjusted return on equity hovers around 27%, and profit margin near 21%.That momentum came even as futur ...

Core Insights - Marex Group plc reports a strong performance in Q3 2025, with revenues expected between $475 million and $485 million, reflecting a 23% year-over-year increase at the midpoint [2] - Adjusted Profit Before Tax is projected to be in the range of $96 million to $101 million, marking a 22% year-over-year increase at the midpoint [2] - The company anticipates full Q3 results to be released on November 6, 2025 [2] Financial Performance - Revenue for Q3 2025 is estimated at $475 million to $485 million, compared to $391 million in Q3 2024 [4] - Adjusted Profit Before Tax is estimated between $96 million and $101 million, up from $81 million in Q3 2024 [4] - Adjusted Return on Equity is approximately 27%, with an Adjusted Profit Before Tax Margin around 21% [2][4] Operational Highlights - Average Clearing Client balances increased by 4% to $13.3 billion in Q3 2025, up from $12.8 billion in Q2 2025 [3] - The company achieved a record of over $10 billion in US client assets in October 2025, as reported by the Commodity Futures Trading Commission [3] - Despite a challenging operating environment with exchange volumes down over 15% on average in Q3 compared to Q2, Marex maintained its growth trajectory [3] Management Commentary - Ian Lowitt, Group CEO, expressed confidence in the company's performance and growth prospects, highlighting the resilience of the business model [3] - The management aims to address investor questions regarding performance and client balances following recent share price movements [3]